We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$138M
AUM Growth
+$9.19M
Cap. Flow
+$1.05M
Cap. Flow %
0.76%
Top 10 Hldgs %
39.61%
Holding
87
New
4
Increased
12
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
OXY icon
Occidental Petroleum
OXY
+$1.57M
2
TTE icon
TotalEnergies
TTE
+$1.25M
3
PFE icon
Pfizer
PFE
+$1.19M
4
T icon
AT&T
T
+$1.06M
5
SLB icon
SLB Ltd
SLB
+$578K

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$634K
2
ABBV icon
AbbVie
ABBV
+$515K
3
AAPL icon
Apple
AAPL
+$502K
4
MSFT icon
Microsoft
MSFT
+$350K
5
CSX icon
CSX Corp
CSX
+$284K

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.81%
2 Healthcare 14.33%
3 Materials 12.87%
4 Technology 8.46%
5 Real Estate 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
26
Bristol-Myers Squibb
BMY
$129B
$1.84M 1.33%
28,675
-300
-1% -$17.2K
KL
27
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$1.82M 1.31%
41,260
-5,100
-11% -$226K
LLY icon
28
Eli Lilly
LLY
$1.08T
$1.75M 1.27%
13,343
-1,059
-7% -$123K
SO icon
29
Southern Company
SO
$108B
$1.72M 1.25%
27,050
-1,000
-4% -$62K
OXY icon
30
Occidental Petroleum
OXY
$55.7B
$1.62M 1.17%
+39,257
New +$1.57M
WPC icon
31
W.P. Carey
WPC
$17B
$1.61M 1.17%
20,573
-613
-3% -$51.4K
CVX icon
32
Chevron
CVX
$382B
$1.57M 1.14%
13,032
-850
-6% -$100K
PSA icon
33
Public Storage
PSA
$61.5B
$1.57M 1.14%
7,374
-200
-3% -$44.4K
VTR icon
34
Ventas
VTR
$47.5B
$1.55M 1.12%
26,894
-1,300
-5% -$81.6K
SH icon
35
ProShares Short S&P500
SH
$928M
$1.51M 1.09%
15,700
-6,275
-29% -$634K
K
36
DELISTED
Kellanova
K
$1.49M 1.08%
22,924
-320
-1% -$19.4K
LMT icon
37
Lockheed Martin
LMT
$131B
$1.44M 1.04%
3,690
-200
-5% -$76.7K
UL icon
38
Unilever
UL
$142B
$1.43M 1.03%
22,191
-89
-0.4% -$5.91K
ABT icon
39
Abbott
ABT
$187B
$1.41M 1.02%
16,283
-1,260
-7% -$106K
KMB icon
40
Kimberly-Clark
KMB
$37.6B
$1.41M 1.02%
10,250
-250
-2% -$33.8K
RTX icon
41
RTX Corp
RTX
$290B
$1.37M 0.99%
14,522
-477
-3% -$43.3K
GILD icon
42
Gilead Sciences
GILD
$165B
$1.34M 0.97%
20,600
-800
-4% -$52.1K
SNY icon
43
Sanofi
SNY
$107B
$1.31M 0.95%
26,175
-534
-2% -$25K
VZ icon
44
Verizon
VZ
$197B
$1.28M 0.93%
20,887
-405
-2% -$24.4K
WY icon
45
Weyerhaeuser
WY
$17.6B
$1.17M 0.85%
38,796
-270
-0.7% -$7.83K
JNJ icon
46
Johnson & Johnson
JNJ
$640B
$1.13M 0.82%
7,750
-700
-8% -$94.9K
AEM icon
47
Agnico Eagle Mines
AEM
$72.2B
$1.01M 0.73%
16,400
-500
-3% -$29K
AUY
48
DELISTED
Yamana Gold, Inc.
AUY
$954K 0.69%
241,575
+16,500
+7% +$58K
DNP icon
49
DNP Select Income Fund
DNP
$4.14B
$943K 0.68%
73,851
COP icon
50
ConocoPhillips
COP
$144B
$855K 0.62%
13,150
-520
-4% -$30.6K

Similar funds

Bennicas & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Bennicas & Associates held 87 positions worth $138M, up 7.1% from $129M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Bennicas & Associates's Q4 2019 filing shows 4 new, 12 increased, 58 reduced and 2 closed positions. Its largest new stake was Occidental Petroleum: 39,257 shares worth $1.62M. The largest sale was ProShares Short S&P500, an estimated $634K.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Materials.

  • Bennicas & Associates's largest Q4 2019 buy was Occidental Petroleum: 39,257 shares worth $1.62M.
  • Bennicas & Associates added most to TotalEnergies in Q4 2019, an estimated $1.25M increase.
  • Bennicas & Associates's biggest Q4 2019 reduction was ProShares Short S&P500, cutting an estimated $634K.
  • Bennicas & Associates fully exited Diversified Healthcare Trust in Q4 2019, selling an estimated $183K.
  • Bennicas & Associates's ten largest holdings make up 40% of its $138M portfolio in Q4 2019.
  • Bennicas & Associates opened 4 new positions and closed 2 in Q4 2019.
  • Bennicas & Associates's portfolio value rose 7.1% quarter-over-quarter to $138M.

Based on Bennicas & Associates's 13F filing for Q4 2019, filed 17 Jan 2020.